Desmoteplase-mediated plasminogen activation and clot lysis are inhibited by the lysine analogue tranexamic acid.
Niego
Be'eri
B
Horvath
Anita
A
Coughlin
Paul B
PB
Pugsley
Michael K
MK
Medcalf
Robert L
RL
D000933:Antifibrinolytic Agents / Q000494:pharmacology*; D004347:Drug Interactions; D005342:Fibrinolysis / Q000187:drug effects* / Q000502:physiology; D005343:Fibrinolytic Agents / Q000009:adverse effects; D006470:Hemorrhage / Q000139:chemically induced / Q000188:drug therapy*; D006801:Humans; D066298:In Vitro Techniques; D010958:Plasminogen / Q000187:drug effects* / Q000502:physiology; D010960:Plasminogen Activators / Q000009:adverse effects; D014148:Tranexamic Acid / Q000494:pharmacology*
D000933:Antifibrinolytic Agents; D005343:Fibrinolytic Agents; C069588:salivary plasminogen activator alpha 1, Desmodus rotundus; D014148:Tranexamic Acid; D010958:Plasminogen; D010960:Plasminogen Activators